Superbowl Ad Sparks A Healthy Controversy About Medication Safety
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
Patients on Ozempic report ‘waking up blind’ in as little as a day after using fat jab
PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
biznews.com4h
🔒 FT’s Big Read: Should weight loss drugs be given to children
Debate over childhood obesity treatments: weight-loss drugs vs. lifestyle changes, with concerns about long-term effects.
Should weight-loss drugs be given to children?
A battle over how to treat childhood obesity is brewing between those in favour and others who warn of the effects on growing bodies ...
Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The ...
Modern Healthcare16h
Ozempic, Wegovy maker responds to Hims & Hers Super Bowl ad
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
Stockhead on MSN18h
Ozempic’s PBS push could shake up ASX food stocks, and here’s how
Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions and more booze-free ...
GLP-1 ad battle—Ozempic and Wegovy maker responds to Hims & Hers Super Bowl debut
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.